ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma

Ge, Zhouhong; Helmijr, Jean C. A.; Jansen, Maurice P. H. M.; Boor, Patrick P. C.; Noordam, Lisanne; Peppelenbosch, Maikel; Kwekkeboom, Jaap; Kraan, Jaco; Sprengers, Dave*
Translational Oncology2021-7DOI: 10.1016/j.tranon.2021.101073
9阅读
引用收藏
分享

摘要

Background and aims: Circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) may be used for diagnostic or prognostic purposes in patients with hepatocellular carcinoma (HCC). We aim to determine whether CTCs or ctDNA are suitable to determine oncogenic mutations in HCC patients. Methods: Twenty-six mostly advanced HCC patients were enrolled. 30 mL peripheral blood from each patient was obtained. CellSearch system was used for CTC detection. A sequencing panel covering 14 cancer-relevant genes was used to identify oncogenic mutations. TERT promoter C228T and C250T mutations were determined by droplet digital PCR. Results: CTCs were detected in 27% (7/26) of subjects but at low numbers (median: 2 cells, range: 1 & ndash;15 cells) and ctDNA in 77% (20/26) of patients. Mutations in ctDNA were identified in several genes: TERT promoter C228T (77%, 20/26), TP53 (23%, 6/26), CTNNB1 (12%, 3/26), PIK3CA (12%, 3/26) and NRAS (4%, 1/26). The TERT C228T mutation was present in all patients with one or more ctDNA mutations, or detectable CTCs. The TERT C228T and TP53 mutations detected in ctDNA were present at higher levels in matched primary HCC tumor tissue. The maximal variant allele frequency (VAF) of ctDNA was linearly correlated with largest tumor size and AFP level (Log10). CtDNA (or TERT C228T) positivity was associated with macrovascular invasion, and positivity of ctDNA (or TERT C228T) or CTCs (>= 2) correlated with poor patient survival. Conclusions: Oncogenic mutations could be detected in ctDNA from advanced HCC patients. CtDNA analysis may serve as a promising liquid biopsy to identify druggable mutations.

学科与关键词

关键词
Circulating tumor DNACirculating tumor cellsTERT promoter mutationsMacrovascular invasionHepatocellular carcinoma
相关
加载中…
  • The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma
    Ding, Yubo; Yao, Jingwei; Wen, Meiling; Liu, Xiong; Huang, Jialu; Zhang, Minghui; Zhang, Yu; Lv, Yufan; Xie, Zhuoyi; Zuo, JianHong*PEErJ, 2022, 10: e13473.被引 3
  • Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma
    Wang, Chunming; Luo, Qiong; Huang, Wenbin; Zhang, Cheng; Liao, Hangyu; Chen, Kunling; Pan, MingXin*Frontiers in Oncology, 2021, 11: 686365.被引 5
  • Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma.
    Wang, Dong; Xu, Yaping; Goldstein, Jennifer B; Ye, Ke; Hu, Xi; Xiao, Liang; Li, Lifeng; Chang, Lianpeng; Guan, Yanfang; Long, Guo; He, Qiongzhi; Yi, Xin; Zhang, Jianjun; Wang, Zhiming; Xia, Xuefeng; Zhou, LeduLiver International, 2020.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Oncology
发表日期
2021-07
卷期
第 14 卷, 第 7 期
页码
101073
DOI
10.1016/j.tranon.2021.101073
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
China Scholarship CouncilChina Scholarship Council [201606230253]; Dutch Society for Gastroenterology (NVGE) [BO/JG/PROJECT 2016-10]

作者

  • G

    Ge, Zhouhong (第一作者)

  • H

    Helmijr, Jean C. A.

查看全部 9 位作者收起作者
  • J

    Jansen, Maurice P. H. M.

  • B

    Boor, Patrick P. C.

  • N

    Noordam, Lisanne

  • P

    Peppelenbosch, Maikel

  • K

    Kwekkeboom, Jaap

  • K

    Kraan, Jaco

  • S

    Sprengers, Dave (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417